Immune System Stimulation by Probiotic Food Supplementation
Maneno muhimu
Kikemikali
Tarehe
Imethibitishwa Mwisho: | 01/31/2017 |
Iliyowasilishwa Kwanza: | 02/07/2017 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 02/08/2017 |
Iliyotumwa Kwanza: | 02/09/2017 |
Sasisho la Mwisho Liliwasilishwa: | 02/08/2017 |
Sasisho la Mwisho Lilichapishwa: | 02/09/2017 |
Tarehe halisi ya kuanza kwa masomo: | 01/07/2016 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 04/09/2016 |
Tarehe ya Kukamilisha Utafiti: | 05/01/2016 |
Hali au ugonjwa
Uingiliaji / matibabu
Dietary Supplement: Weiquan Yogurt with probiotics
Dietary Supplement: Weiquan Yogurt without probiotics
Awamu
Vikundi vya Arm
Mkono | Uingiliaji / matibabu |
---|---|
Experimental: Weiquan Yogurt with probiotics Weiquan Yogurt with probiotics contained Lactobacillus paracasei (108 colony forming units (CFU)/ml), Lactobacillus casei 431® (108 CFU/ml) and Lactobacillus fermentum PCC® (106 CFU/ml) | Dietary Supplement: Weiquan Yogurt with probiotics 150 ml daily consumption for a total of 12 weeks |
Placebo Comparator: Weiquan Yogurt without probiotics Weiquan Yogurt devoid of probiotics, but otherwise similar to the experimental product. | Dietary Supplement: Weiquan Yogurt without probiotics 150 ml daily consumption for a total of 12 weeks |
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 25 Years Kwa 25 Years |
Jinsia Inastahiki Kujifunza | All |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - male or female between 25 to 45 years old; - having caught the common cold or flu at least 4 to 6 times in the past calendar year; - signed the informed consent forms before entering the study; - fully understood the risks and potential benefits in participating this study. Exclusion Criteria: - were diagnosed with the decreased immunity caused by any diagnosed chronic illness; - having any gastrointestinal illness with medical treatment at the time of being enrolled; - having any diagnosed respiratory illness with similar symptoms as the common cold and flu; - currently taking any pain killer drug; - having received any vaccine for the upper respiratory infection within 6 months before enrollment; - having received any purgative drug or digestion related drug within 2 weeks before enrollment; - having taken any dairy product containing prebiotics and probiotics within 10 days before enrollment; - currently taking any preventive drug for upper respiratory infection; - having received any drug which has impact with the immune system such as antibiotics within 3 months before enrollment; - alcoholic or addicted to any drug; - pregnant or breastfeeding mothers; - having participated another clinical trial within 3 months before enrollment. |
Matokeo
Hatua za Matokeo ya Msingi
1. Incidence of flue symptoms during the study [end of week 12]
Hatua za Matokeo ya Sekondari
1. Incidence of cold symptoms during the study [end of week 12]
2. Number of accumulated days of having cold symptoms during the study [End of week 12]
3. Serum IFN-γ concentration [Baseline, end of week 12]
4. Serum IL-4 concentration [Baseline, end of week 12]
5. Serum IL-10 concentration [Baseline, end of week 12]
6. Serum IgA concentration [Baseline, end of week 12]
7. Serum IgG concentration [Baseline, end of week 12]
8. Serum IgM concentration [Baseline, end of week 12]
9. Fecal sIgA concentration [Baseline, end of week 12]